Hennion & Walsh Asset Management’s MacroGenics MGNX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,207	Closed	-$267K	–	827
2023 Q1	$267K	Sell	37,207 -1,275	-3%	-$7.68K	0.02%	674
2022 Q4	$258K	Buy	38,482 +4,865	+14%	+$26.7K	0.02%	679
2022 Q3	$116K	Sell	33,617 -466	-1%	-$1.78K	0.01%	750
2022 Q2	$101K	Sell	34,083 -507	-1%	-$2.67K	0.01%	750
2022 Q1	$305K	Buy	34,590 +706	+2%	+$7.79K	0.02%	654
2021 Q4	$544K	Buy	33,884 +2,120	+7%	+$39.9K	0.03%	523
2021 Q3	$665K	Buy	31,764 +10,877	+52%	+$262K	0.03%	446
2021 Q2	$561K	Buy	+20,887	New	+$612K	0.03%	496

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hennion & Walsh Asset Management's MGNX Position: Q2 2023 in Review

Hennion & Walsh Asset Management sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 37,207 shares — an estimated $267K sold.

Hennion & Walsh Asset Management first reported a position in MGNX in Q2 2021 and held it in 8 quarters. The position peaked at $665K in Q3 2021. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

Hennion & Walsh Asset Management reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 37,207 MacroGenics shares in Q2 2023, an estimated $267K.
Hennion & Walsh Asset Management first reported a position in MacroGenics in Q2 2021 and held it in 8 quarters.
Hennion & Walsh Asset Management's MacroGenics position peaked at $665K in Q3 2021.
131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.